2 Clinical Trials for Various Conditions
Whole blood and urine samples will be collected from pregnant woman of gestational age 36-56 days as confirmed by artificial reproductive technology (ART). The samples will be used to develop a prenatal sex test using circulating cell free fetal DNA (ccffDNA) in maternal plasma or urine.
Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.